PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jcbnLink to Publisher's site
 
J Clin Biochem Nutr. Nov 2008; 43(3): 167–174.
Published online Oct 31, 2008. doi:  10.3164/jcbn.2008060
PMCID: PMC2581758
The Modifying Effects of Galactomannan from Canadian-Grown Fenugreek (Trigonella foenum-graecum L.) on the Glycemic and Lipidemic Status in Rats
Anchalee Srichamroen,1 Catherine J. Field,1 Alan B.R. Thomson,2 and Tapan K. Basu1*
1Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta T6G 2P5, Canada
2Division of Gastroenterology, Zeidler Ledcor Center, University of Alberta, Edmonton, Alberta T6G 2X8, Canada
*To whom correspondence should be addressed. Tel: +1-780-492-5338 Fax: +1-780-492-4265 E-mail: tapan.basu/at/ualberta.ca
Received January 8, 2008; Accepted May 4, 2008.
Using high sucrose-fed male Sprague-Dawley rats, a study was conducted to determine the effects of feeding Galactomannan (GAL), a soluble dietary fiber extracted from Canadian-grown fenugreek seeds, on blood lipid and glucose responses. Rats (n = 8, 175–200 g) were randomly assigned to one of three high sucrose diets containing 10% cellulose (control), 7.5% cellulose + 2.5% GAL, and 5% cellulose + 5% GAL, respectively for 4 weeks. After 3 weeks, an oral glucose tolerance test (OGTT) was performed on each rat. A week later blood samples were collected to determine the effect on blood lipids. A significant reduction in glycemic response was observed only in 5% GAL group at 120 min following OGTT, when compared with that of control and 2.5% GAL groups. The plasma level of insulin was also significantly reduced (p<0.001) in 5% GAL-fed rats but at all times during OGTT. These animals also showed a reduction in body weight gain (p<0.05) in parallel with less food intake (p<0.05). All GAL-fed (2.5% and 5.0%) rats had significantly reduced plasma levels of triglycerides and total cholesterol in association with a reduction in epididymal adipose weight. Overall, this study demonstrated that feeding GAL from Canadian-grown fenugreek seeds has the potential to alter glycemic and lipidemic status and reduce abdominal fat in normal rats.
Keywords: Canadian fenugreek seed, galactomannan, glycemic status, lipidemic status, epididymal tissue
Fenugreek (Trigonella foenum-graecum L.) is an annual dicotyledon plant belonging to the family Papilionaceae Leguminsae and is thought to originate in India and Middle East. The seeds contain sapogenins, OH-isoleucine and galactomannans, which have been shown to exert beneficial health effects, specifically in diabetic and hypercholesterolemic animals and humans [1]. Among the potential active components of fenugreek seeds is galactomannan (GAL), which is a guar gum representing approximately 50% of the seed weight [2].
GAL extracted from fenugreek seeds of South Asian origin has been shown to reduce postprandial blood glucose [3] and improve insulin sensitivity in both non-diabetic [4, 5] and diabetic subjects [68]. The decrease in postprandial blood glucose reduced the need for antidiabetic medication, including insulin, in diabetic subjects consuming diets containing guar gum. Feeding guar-GAL fibre has also been shown to reduce both total and LDL cholesterol levels in healthy and type 2 diabetic (T2D) subjects [9, 10]. However, these results are not consistent among all studies. A guar gum-containing diet, given for 4 weeks, failed to show an improvement in glucose control in T2D subjects [11], while a long-term ingestion of the fiber has been found to be associated with increased plasma insulin concentrations [12]. Further studies, involving healthy male subjects, also reported no appreciable effects of the fiber in modifying glycemic status [13]. It is possible that the discrepancies in glycemic responses to GAL intake are caused by the differences in the fiber concentrations, type of foods, and duration of the studies.
In recent years, fenugreek plant has been adapted to cultivation in a Canadian province, Alberta. Unlike the Asian variety of the plant, the potential health benefit of GAL of this Canadian fenugreek has never been studied. The present study was undertaken to examine the effects of feeding GAL, isolated and purified from Canadian-grown fenugreek seeds, in a high sucrose diet on blood lipids and glycemic responses in normal Sprague-Dawley rats. The high sucrose diet was chosen because of its established effects on increasing triglycerides (TG) in both plasma and adipose tissue [14].
Materials
GAL was extracted from fenugreek seeds (Amber variety) in our laboratory. Briefly, seed coat fraction (0.5 mm mesh) was dispersed in RO water, at a ratio of 1:40 (w/v) for 4 h. After centrifugation at 17,700 × g for 30 min, the supernatant was mixed with absolute ethanol at a ratio of 1:1 (v/v) to precipitate the fenugreek gum, which contained 91.4% (w/w) GAL on a dry weight basis.
Animals and diets
Twenty-five male Sprague-Dawley rats (weighing 175–200 g) were obtained from Charles River Laboratories (Ontario, Canada). The animals were housed two per cage at 20–22°C and subjected to a 12-h day/night cycle. After a week of acclimatization, animals were randomly divided into three groups, which were fed a diet containing 0% (control, n = 9), 2.5% (low, n = 8), and 5% (high, n = 8) GAL. Initial body weights of these animals were similar. All rats had ad libitum access to water and food during the experiment. The diets were high in sucrose (52% w/w), isocaloric and isonitrogenous, and they contained 10% w/w fibre, differed only in it’s composition as shown in Table 1. All diets contained some cellulose, a non-fermentable and non-soluble fiber, which was necessary to minimize the risk of soluble fiber-associated diarrhea. The body weight and the food intake were measured daily. The protocol of the study was approved by the Faculty of Agriculture, Forestry and Home Economics’ Animal Policy and Welfare Committee (FAPWC), University of Alberta, Canada.
Table 1
Table 1
Composition of diets
Oral glucose tolerance test
Animals were fed their respective diet for 3 weeks. Following 12 h fast, each rat received an oral gavage of 75% w/v glucose (3 g/kg BW). Blood samples were obtained from tail at 0, 15, 30, 60, and 120 min after the glucose challenge. Using the following calculation, the plasma and insulin responses were determined as the area under the curve (AUC) of plasma glucose and insulin:
AUC = 1/2(t2 − t1)(C2 + C1) + 1/2(t3 − t2)(C3 + C2) + 1/2(t4 − t3)(C4 + C3) + 1/2(t5 − t4)(C5 + C4),
Where C1, C2, C3, C4 and C5 are either plasma glucose or plasma insulin at times 0 (t1), 15 (t2), 30 (t3), 60 (t4) and 120 min (t5), respectively, after glucose load.
Blood and tissue sampling
At the termination of the experiment (day 28), animals were fasted for 12 h and anaesthetized with halothane. Cardiac puncture was performed to obtain sufficient blood for biochemical analyses. Tubes containing whole blood were centrifuged at 3000 rpm for 15 min at 4°C (Beckman J2-HC centrifuge, City, CA). The plasma samples were stored at −80°C until analyzed. At necropsy, liver, epididymal and peri-renal fat depots were excised, weighed, snap frozen in liquid nitrogen and then stored at −80°C until analysed.
Biochemical analyses in plasma and tissue
Plasma glucose and insulin concentrations were determined by a glucose oxidase method (Biopacific Diagnostic Inc., British Columbia, Canada) and a RIA kit [125I] (Linco Research, City, MO), respectively. Plasma cholesterol and triglyceride were determined using commercially available enzymatic kits (Biopacific Diagnostic Inc.). Total free fatty acids (FFA) in plasma were measured by using NEFA-C Test Wako kit (Wako Pure Chemical Industries, City, VA).
Plasma lipoprotein fractions were separated by density gradient ultracentrifugation (Optima MAX Ultracentrifuge, Beckman coulter, City, CA) at 100,000 rpm for 3, 4, and 6 h to obtain the fraction of VLDL, LDL, and HDL, respectively, as described elsewhere (Wasan et al., 2001). The different triglyceride and cholesterol molecules were fractionated as follows: VLDL had a density (d) of 0.095–1.006 kg/L, LDL had d = 1.006–1.063 kg/L, HDL had d >1.063 kg/L [15]. Triglyceride and cholesterol concentrations were determined for each of the fractions using enzymatic kits (Biopacific Diagnostic Inc.).
Lipid from liver and adipose tissues was extracted by chloroform/ methanol (2:1, v/v) solution as described by Folch et al. [16]. Triglyceride and cholesterol concentrations were measured using commercially available enzymatic kit (Biopacific Diagnostic Inc.).
Adipose tissue histology
Difference in epididymal histology was determined by analyzing two representative animals from each treatment group. Frozen epididymal adipose tissues were thawed and fixed in 10% (v/v) formalin. After 48 h of fixation, tissues were dehydrated in graded alcohols, embedded in paraffin blocks, and cut into sections of 5 µm thick. Mounted sections were stained for light microscopy with haematoxylin and eosin using standard methods [17]. The samples were analyzed by an individual, who was blinded to the diet treatment that the animals received.
Statistical analyses
Results were reported as the mean ± SEM. Statistical analysis was performed by using one-way analysis of variance (ANOVA), followed by Student-Newman-Keuls (SNK) test as a post-hoc analysis to identify significant differences among the groups. A p value<0.05 was considered statistical significance. Group means for body weight, plasma glucose and plasma insulin, AUC were calculated by repeated measurement analysis. The differences of AUC between time points were determined using repeated measurement analysis, and a SNK test was performed to identify differences.
Food intake, body and tissue weights
Food intake was significantly reduced by 16%, and 12% for the high GAL group when compared with the control and low GAL groups, respectively (p<0.05, Table 2). Body weight of rats in all groups increased steadily with time, but the average body weight of the animals fed a diet containing high GAL diet was significantly lower on day 10 (by 6%) and on day 28 (by 11%) compared to the control and the low GAL groups (data not shown). Furthermore, the overall body weight gain in the high GAL group was significantly lower compared to the control and the low GAL groups (p<0.05, Table 2). There were no differences in overall body weight gain between the low GAL group and the controls. The ratio of weight gain to gram of food intake in all 3 groups did not differ significantly (Table 2).
Table 2
Table 2
Effect of galactomannan on food intake, weight gain, and adipose tissue weight
The low and high GAL groups had significantly less epididymal adipose tissue than the control group by 23% and 56%, respectively (p<0.05, Table 2). However, there were no significant differences in the weight of peri-renal adipose tissue depot among these groups.
Oral glucose tolerance test
The average fasting plasma glucose concentration for the high GAL group was reduced compared to the low GAL and the control groups (p<0.05, results not shown). After the OGTT, plasma glucose concentrations did not differ significantly at 15, 30, and 60 min, while the glucose concentrations in the high GAL group was significantly lower at 120 min as compared to the low GAL and the control groups (p<0.05).
AUC between 0 and 120 min for glucose of high GAL group was significantly reduced compared to the control and low GAL groups (Table 3). Separate analysis of glucose AUC between 30 and 60 min confirmed that the AUC for the high GAL group was significantly lower than the control. Between 60 to 120 min, the AUC of both low and high GAL groups were significantly lower compared to the control group. There were no differences in glucose AUC at 15 min (AUC 0 to 15 min), 30 min (AUC 15 to 30 min) among all three groups.
Table 3
Table 3
Area under the curve of plasma glucose after OGTT
Fasting plasma insulin in the high GAL group was lower than that of the low GAL and the control groups (p<0.001, Fig. 1). After the OGTT, plasma insulin of the high GAL group was lower than the insulin levels of the low GAL and control groups at 15, 30, 60 and 120 min (p<0.001). There were no differences in plasma insulin concentrations between the control and the low GAL groups.
Fig. 1
Fig. 1
Plasma insulin response to the OGTT in rats fed one of three diets for 3 weeks.
Feeding both low and high GAL diets to rats resulted in significantly lower AUC for insulin between 0 and 120 min compared to the control (Table 4). The AUC for the high GAL group was significantly lower than the control at all measured time points. In low GAL group, compared to the control group, there was a significantly lower AUC for insulin at every measured time point, except at 30 min (AUC 15 to 30 min).
Table 4
Table 4
Area under the curve of plasma insulin after OGTT
Triglyceride, free fatty acids and cholesterol concentrations
Both the low and high GAL groups had lower (p<0.05) plasma triglyceride and cholesterol concentrations, compared to the control (Fig. 2), while plasma FFA in the low GAL group was significantly lower (Fig. 2). The plasma FFA was found to be reduced only in the low GAL group. VLDL triglyceride and cholesterol concentrations in plasma did not differ significantly among diet treatments (Fig. 3 and and4).4). High GAL group, however, had significantly lower LDL- and HDL-TG concentrations than those of the control animals. The low but not the high GAL group had significantly lower concentrations of hepatic TG (p<0.05) than the control (Fig. 5). Compared with the controls the hepatic cholesterol concentration was, however, lower in both low and high GAL groups.
Fig. 2
Fig. 2
Plasma levels of total-triglyceride, total cholesterol, and FFA in rats fed with different diets for 4 weeks.
Fig. 3
Fig. 3
Lipoprotein triglyceride levels in rats fed with different diets for 4 weeks.
Fig. 4
Fig. 4
Lipoprotein cholesterol levels in rats fed with different diets for 4 weeks.
Fig. 5
Fig. 5
Hepatic triglyceride and cholesterol levels in rats fed with different diets for 4 weeks.
Adipose fat
Epididymal triglyceride concentrations in the high GAL group were reduced by 20% when compared to the control group (p<0.05, Fig. 6). Upon histological examination the epididymal adipose tissue of these animals was visibly different from the control and low GAL-fed animals (Fig. 7). The changes that were found to be present in the presence of GAL included clusters of large fat cells surrounded by small fat cells throughout adipose tissues, and capillaries that appeared to be filled with erythrocytes.
Fig. 6
Fig. 6
Epididymal triglyceride level in rats fed with different diets for 4 weeks.
Fig. 7
Fig. 7
Histology of epididymal adipose tissues from rats fed a diet containing different levels of galactomannan for 4 weeks.
Fenugreek is a native of the Indian sub-continent and the Eastern region. Its high adaptability to dry climate, high yield and their ability to fix atmospheric nitrogen (N) make it an ideal for short-term crop rotation in Northern countries, such as Canada. An examination in our laboratory has revealed that the Canadian-grown fenugreek seeds and the seeds of a fenugreek variety, grown in India, are of similar appearances, color, size, shape, odor, and anatomical features. The chemical composition (e.g., crude lipids, 4-hydroxyisoleucine, saponins) of Canadian fenugreek seeds has also been found to be very similar to that of the seeds of Indian origin. The Canadian variety, however, is significantly higher in crude protein and GAL contents (unpublished data).
In rats, a high sucrose diet has been reported to result hypertriglyceridemia, hyperglycemia, and hyperinsulinemia [18, 19]. The diet is also known to impair insulin action, leading to hypertriglyceridemia [20, 21]. In the present study, an addition of 5% GAL to a high sucrose diet resulted in a marked reduction in food intake in parallel with body weight gain in rats, when fed for 4 weeks. GAL belongs to a family of seed gum; it represents polymers of galactose and mannose, and it is soluble in water [22]. Most soluble gum fibers, such as guar gum, xanthan gum, gum acacia and locust bean gum are viscous and that this property is thought to delay gastric emptying and consequently intestinal absorption [23]. However, the ratio of body weight gain to food intake in all 3 groups in this study was similar. These data indicated that the reduction in weight gain in the high GAL group was likely due to reduced food intake, rather than malabsorption. The fiber intake was also found to be accompanied by a decreased rise in plasma insulin, which is an important factor for appetite control [24]. It seems probable that the reduced food intake in the presence of GAL is caused by delaying in gastric empty (due to viscosity) and promoting satiety (due to insulin inhibition) of the soluble fiber. These results are in agreement with our previous in vitro study demonstrating reduced intestinal glucose uptake with increasing GAL concentration in lean and obese JCR rats [25]. This inhibition was found to be associated with an increase in the viscosity of the GAL-containing test solutions.
The present study was the first to demonstrate that feeding a GAL diet for 4 weeks to normal rats, markedly reduces the size of the abdominal adipose tissues compared with the control counterpart, fed a similar diet but containing an equivalent amount of cellulose as a fiber source. This result can be explained by a decrease in insulin level leading to reduced lipogenesis. The evidence of abdominal adipose tissue histology from rats fed with 5% GAL containing diet is suggestive of a high metabolic rate in the tissue, leading to a release of FFA into the circulation.
One of the plausible mechanisms linking visceral adiposity to insulin resistance is the liberation of non-esterified fatty acids (NEFAs) from visceral depots to the liver. This NEFAs in the liver, therefore, have a particularly important role in bringing about many features of insulin resistance. Stimulation of hepatic glucose synthesis may contribute to glucose intolerance [26]. Stimulation of hepatic VLDL-TG secretion may contribute to impaired postprandial lipid metabolism (via competition with chylomicron-TG for peripheral clearance) and the development of hypertriglyceridemia. Given these facts, the high plasma and hepatic FFA in rats fed a diet containing 5% GAL for 4 weeks, observed in the present study, do not reflect insulin resistance. These rats had lower plasma TG, while VLDL-TG levels remained unchanged compared to the controls. The OGTT in these animals also remained unaffected. These results indicate that an underlying factor for the reduction of plasma insulin level in GAL-fed rats may increase lipolysis in adipose tissue, and consequently an increased plasma FFA levels and a reduced adipocyte size. The GAL-associated decrease is also accompanied by reductions in plasma and hepatic concentrations of triglycerides, total cholesterol, and LDL-cholesterol. These findings are in agreement with others, which reported similar effects using other viscous fibers [27, 28]. The hypocholesterolemic effects of soluble fibers may slow glucose absorption, because of their viscosity as well as by binding bile acids in the intestinal lumen leading to a decreased enterohepatic circulation [29]. Furthermore, viscous fibers have been shown to increase the number of LDL receptors in the liver of rats [30, 31]. An up-regulation of the LDL receptors, therefore, increases clearance of LDL cholesterol. The results of reduced hepatic cholesterol and plasma LDL cholesterol in the present study, thus, suggest the possibility of an increased clearance of cholesterol in the liver.
In summary, GAL at 2.5% and 5% (w/w) reduced plasma triglyceride, cholesterol and hepatic cholesterol concentrations. GAL at 5% (w/w) resulted in lower food intake, which may have enhanced the release of plasma FFA, and in turn, led to the least amount (i.e. weight) of epididymal adipose tissue. These results clearly demonstrate that GAL from Canadian-grown fenugreek, a novel source of dietary fiber, has the potential benefits in modifying both glycemic and lipidemic status as well as body weight.
Acknowledgements
The authors would like to thank Dr. S.N. Acharya, Lethbridge Research Centre, Alberta, for his courtesy to provide fenugreek seeds, Dr. P. Nation, Health Sciences Laboratory Animal Services (HSLAS), University of Alberta, for his histology technical support, and Donna Taylor, Department of Agriciltural, Food & Nutritional Science, University of Alberta, for providing animal care. This study was supported by grants received from the AVAC Ltd.
1. Srinivasan K. Plant foods in the management of diabetes mellitus: Spices as beneficial antidiabetic food adjuncts. Int. J. Food Sci. Nutr. 2005;56:399–414. [PubMed]
2. Raghuram T.C., Sharma R.D., Sivakumar B. Effect of fenugreek seeds on intravenous glucose disposition in non-insulin dependent diabetic patients. Phytother. Res. 1994;8:83–86.
3. Sharma R.D. Effect of fenugreek seeds and leaves on blood glucose and serum insulin responses in human subjects. Nutr. Res. 1986;6:1353–1360.
4. Jenkins D.J. Diabetic glucose control, lipids, and trace elements on long-term guar. Br. Med. J. 1980;1:1353. [PMC free article] [PubMed]
5. Fairchild R.M., Ellis P.R., Byrne A.J., Luzio S.D., Mir M.A. A new breakfast cereal containing guar gum reduces postprandial plasma glucose and insulin concentrations in normal-weight human subjects. Br. J. Nutr. 1996;76:63–73. [PubMed]
6. Jenkins D.J. Guar crispbread in the diabetic diet. Br. Med. J. 1978;2:1744. [PMC free article] [PubMed]
7. Sels J.P., Flendrig J.A., Postmes T.J. The influence of guar gum bread on the regulation of diabetes mellitus type II in elderly patients. Br. J. Nutr. 1987;57:177–180. [PubMed]
8. Pick M.E. Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. J. Am. Diet. Assoc. 1996;96:1254. [PubMed]
9. Jenkins D.J. Effect of guar crispbread with cereal products and leguminous seeds on blood glucose concentrations of diabetics. Br. Med. J. 1980;281:1248–1252. [PMC free article] [PubMed]
10. Landin K., Holm G., Tengborn L., Smith U. Guar gum improves insulin sensitivity, blood lipids, blood pressure, and fibrinolysis in healthy men. Am. J. Clin. Nutr. 1992;56:1061–1065. [PubMed]
11. Uusitupa M., Siitonen O., Savolainen K., Silvasti M., Penttil I., Parviainen M. Metabolic and nutritional effects of long-term use of guar gum in the treatment of non-insulin-dependent diabetes of poor metabolic control. Am. J. Clin. Nutr. 1989;49:345–351. [PubMed]
12. Groop P.H., Aro A., Stenman S., Groop L. Long-term effects of guar gum in subjects with non-insulin dependent diabetes mellitus. Am. J. Clin. Nutr. 1993;58:513–518. [PubMed]
13. Nieuwenhoven M.A., Kovacs E.M.R., Brummer R.M., Westerterp-Plantenga M.S., Brouns F. The effect of different dosages of guar gum on gastric emptying and small intestinal transit of a consumed semisolid meal. J. Am. Coll. Nutr. 2001;20:87–91. [PubMed]
14. Aghelli N., Kabir M., Berni-Canani S., Petijean E., Boussairi A., Luo J. Plasma lipids and fatty acid synthase activity are regulated by short-chain fructo-oligosaccharides in sucrose-fed insulin-resistant rats. J. Nutr. 1998;128:1283–1288. [PubMed]
15. Wasan K.M., Cassidy S.M., Kennedy A.L., Peteherych K.D. Lipoprotein isolation and anylysis from serum by preparative ultracentrifugation. In: Drew AF, ed. Atherosclerosis: Experimental Methods and Protocols. Humana press Inc; New Jersey, USA: 2001. pp. 27–35.
16. Folch J., Lees M., Sloane-Stanley G. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957;226:497–509. [PubMed]
17. Ludwig M., Johannes S., Bergmann M., Failing K., Schiefer H.G., Weidner W. Experimental Escherichia coli epi didymitis in rats: a model to assess the outcome of antibiotic treatment. BJU International. 2002;90:933–938. [PubMed]
18. Chicco A., Basabe J.C., Karabatas L., Ferraris N., Fortino A., Lombardo Y.B. Troglitazone (CS-045) normalizes hypertriglyceridemia and restores the altered pattern of glucose-stimulated insulin secretion in dyslipemic rats. Metabolism. 2000;49:1346–1351. [PubMed]
19. Soria A., Chicco A., D’Alessandro M.E., Rossi A., Lombardo Y.B. Dietary fish oil reverse epididymal tissue adiposity, cell hypertrophy and insulin resistance in dyslipemic sucrose fed rat model. J. Nutr. Biochem. 2002;13:209–218. [PubMed]
20. Gutman R., Basilico M.Z., Bernal C., Chicco A., Lombardo Y.B. Long-term hypertriglyceridemia and glucose intolerance in rats fed chronically an isocaloric sucrose-rich diet. Metabolism. 1987;36:1013–1020. [PubMed]
21. Pagliosotti M.J., Shahrokhi K.A., Moscarello M. Involvement of liver and Skeletal muscle in sucrose-induced insulin resistance: Dose-response studies. Am. J. Physiol. 1994;266:R1637–1644. [PubMed]
22. Buckeridge M.S., Panegassi V.R., Rocha D.C., Dietrich S.M.C. Seed galactomannan in the classification and evolution of the leguminosae. Phytochem. 1995;38:871–875.
23. Evans A.J., Hood R.L., Oakenfull D.G., Sidhu G.S. Relationship between structure and function of dietary fiber: A comparative study of three galactomannan on cholesterol metabolism in rats. Br. J. Nutr. 1992;68:217–229. [PubMed]
24. Ebeling P., Yki-Jarvinen H., Aro A., Helve E. Glucose and lipid metabolism and insulin sensitivity in type 1 diabetes: The effect of guar gum. Am. J. Clin. Nutr. 1988;48:98–103. [PubMed]
25. Srichamroen A., Thomson A.B.R., Field C.J., Basu T.K. The inhibiting effect of galactomannan of Canadian-grown fenugreek (Trigonella foenumgraecum) on the intestinal glucose uptake in lean and obese JCR rats; Nutr. Res.; (submitted)
26. Anderson J.W. Dietary fiber and human health. Hort. Science. 1990;25:1488–1495.
27. Ferrannini E., Barrett E.J., Bevilacqua S., DeFronzo R.A. Effect of fatty acids on glucose production and utilization in man. J. Clin. Invest. 1983;72:1737–1747. [PMC free article] [PubMed]
28. Chen W.L., Anderson J.W., Gould M.R. Cholesterol-lowering effects of oat bran and oat gum. Nutr. Rep. Int. 1981;24:1093–1098.
29. Watters K., Blaisdell P. Reduction of glycemic and lipid levels in ob/ob diabetic mice by Psyllium plant fiber. Diabetes. 1989;38:1528–1530. [PubMed]
30. Lia A., Hallmans G., Sandberg A.S., Sundby B., Aman P., Andersson H. Oat b-glucan increases bile acid excretion and a fiber-rich barley fraction increases cholesterol excretion in ileostomy subjects. Am. J. Clin. Nutr. 1995;62:1245–1251. [PubMed]
31. Abbey M., Triantafilidis C., Topping D.L. Dietary non-starch polysaccharides interact with cholesterol and fish oil in their effects on plasma lipids and hepatic lipoprotein receptor activity in rats. J. Nutr. 1993;123:900–908. [PubMed]
Articles from Journal of Clinical Biochemistry and Nutrition are provided here courtesy of
The Society for Free Radical Research Japan